Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

AstraZeneca · Phase 2 · Terminated · Enrollment 213

NCT01235741

ArmPopulationDoseWeeksEstimandWeight change
Group AObesity or overweightn/r16n/rn/r
Group BObesity or overweightn/r16n/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r
Pramlintide + MetreleptinObesity or overweightn/rn/rn/rn/r